Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.

Ravi Rajaram,Arlene M Correa,Ting Xu,Quynh-Nhu Nguyen,Mara B Antonoff,David Rice,Reza Mehran,Jack Roth,Garrett Walsh,Stephen Swisher,Wayne L Hofstetter,Ara Vaporciyan,Tina Cascone,Anne S Tsao,Vassiliki A Papadimitrakopoulou,Saumil Gandhi,Zhongxing Liao,Boris Sepesi

Clinical Lung Cancer（2020）

引用 10|浏览115

暂无评分

摘要

Stage IIIA (N2) NSCLC continues to be a heterogeneous disease, and patients with surgically resected and unresected disease represent different risk populations. Ongoing immunotherapy trials may further redefine treatment algorithms in this complex patient population.

查看译文

关键词

Chemoradiation,Lobectomy,Outcomes research,Recurrence,Surgery

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要